Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2005
10/20/2005WO2005098048A1 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents
10/20/2005WO2005098017A1 Method for production of peptide banks
10/20/2005WO2005098003A1 Mutated prokaryotic cells with high secretion-levels
10/20/2005WO2005098000A1 Recombinant d-amino acid oxidase
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097195A2 Methods of reducing aggregation of il-1ra
10/20/2005WO2005097156A1 Remedy for neurodegenerative diseases
10/20/2005WO2005096706A2 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
10/20/2005WO2005078077A3 Acid alpha-glucosidase and fragments thereof
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050233418 Cytokine polypeptides
10/20/2005US20050233417 Growth hormone variations in humans and their uses
10/20/2005US20050233415 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free
10/20/2005US20050233412 An artificial mutant tRNA synthetase; aminoacylates an orthogonal tRNA with beta -GlcNAc-serine
10/20/2005US20050233411 Compositions and methods for cleaving IAP
10/20/2005US20050233385 Using antibodies on cell surfaces
10/20/2005US20050233381 Libraries of oligonucleotides created by genetic engineering
10/20/2005US20050233380 High throughput discovery of materials through vapor phase synthesis
10/20/2005US20050233379 Methods of antagonizing morphogens
10/20/2005US20050233374 Reagents and methods useful for detecting diseases of the prostate
10/20/2005US20050233355 Human cDNAs encoding polypeptides having kinase functions
10/20/2005US20050233323 Novel protein and dna thereof
10/20/2005US20050233322 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
10/20/2005US20050233308 Method for modifying a property of a protein
10/20/2005US20050233305 Sugar chain library constructed via cargo receptor gene modification
10/20/2005US20050232940 Recombinant plasmid and a method of controlling the effects of yersinia pestis
10/20/2005US20050232936 Meningococcus adhesins nada, app and orf 40
10/20/2005US20050232929 detect, screen, and quantitate biological samples after administration of antibody conjugates, antibody-drug conjugates, antibodies, and fragments and metabolites thereof, by affinity separation, chromatography, and mass spectrometry; monomethyl auristatin drug and a thio-ether linkage
10/20/2005US20050232914 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof
10/20/2005US20050232910 Comprises sakacine G polypeptide for preventing bacterial propagation during food processing; potentially valuable for preserving fermented food products in terms of quality and health
10/20/2005CA2563887A1 Mite allergen zen 1
10/20/2005CA2563513A1 Remedy for neurodegenerative diseases
10/20/2005CA2560504A1 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents
10/19/2005EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins
10/19/2005EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586580A2 Process for the purification of daptomycin
10/19/2005EP1586329A1 Botulinum toxin pharmaceutical compositions
10/19/2005EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2005EP1585810A1 Method for culturing cells in order to produce substances
10/19/2005EP1492879A4 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
10/19/2005EP1353948B1 Soluble cyclic analogues of the beta amyloide peptide
10/19/2005EP1346045B1 Human protooncogene and protein encoded therein
10/19/2005EP1307482B1 Two coloured fluorimetric protease assay
10/19/2005EP1259251B1 Novel method for down-regulation of amyloid
10/19/2005EP1015583B1 Protein containing an srcr domain
10/19/2005EP1007633B1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof
10/19/2005EP0871354B1 Hypersensitive response induced resistance in plants
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/19/2005EP0771208B1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685058A Peptides with anti-hypertensive properties
10/19/2005CN1685057A Methods for producing biological substances in pigment-deficient mutants of bacillus cells
10/19/2005CN1685056A Production method for iturin A and its homologues
10/19/2005CN1684974A Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
10/19/2005CN1684591A Method for production of peptides/amino acids, peptides/amino acids produced by said method and use of the same
10/19/2005CN1683551A Method for preparing cow fetus agent by composite enzyme method and its composite health product
10/19/2005CN1683550A Collagen and its preparing process
10/19/2005CN1683411A Lefteye flonder lymphocystic virus neutralizing monoclonal antibody and its preparing method
10/19/2005CN1683396A Polypeptide capable of inhibiting typhsid bacillus from invading human body cell and its preparing method
10/19/2005CN1683008A Collagen polypeptide preparation for supplementing calcium and its preparing method
10/19/2005CN1682682A Hair tension and hardness improving agent
10/19/2005CN1223677C Gene associated with esophagus cancer
10/19/2005CN1223607C Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application
10/19/2005CN1223605C Polypeptide medicine for inhibiting SARS corona virus, and derivatives and use thereof
10/18/2005US6956112 Fluorescent protein; for use as a diagnostic tool in the treatment of cancer, inflammation and apoptosis defects
10/18/2005US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses
10/18/2005US6956104 Proteins for use in the treatment and diagnosis of brain and nervous system disorders
10/18/2005US6956102 Human N-methyl-D-aspartate receptor subunits nucleic acids encoding same and uses therefor
10/18/2005US6955916 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
10/18/2005US6955913 spray drying; heating; for use in cosmetics/shampoos
10/18/2005US6955910 Method for large scale production of recombinant DNA-derived TPA or K2S molecules
10/18/2005US6955899 comprises collagen-like domain; tissue remodeling
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005CA2338820C Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression
10/18/2005CA2006929C Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
10/13/2005WO2005095624A2 Filamentous fungal mutants with improved homologous recombination efficiency
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
10/13/2005WO2005095600A1 Heparin-binding protein having heparan sulfate sugar chain attached thereto, process for producing the same and medicinal composition containing the same
10/13/2005WO2005095598A1 Cancer antigen peptide originating in wt1
10/13/2005WO2005095582A2 Novel cell culture medium supplements
10/13/2005WO2005095331A1 Agent for binding sugar chain to peptide
10/13/2005WO2005094900A1 Preventive and/or remedy for cancer
10/13/2005WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
10/13/2005WO2005094446A2 Anti-myostatin antibodies
10/13/2005WO2005094356A2 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
10/13/2005WO2005094355A2 Methods for altering protein production rates
10/13/2005WO2005080420A3 Hyphal growth in fungi
10/13/2005WO2005051291A3 B-cell-targeted toxin for immuno response reduction
10/13/2005WO2005014788A3 Tssk4: a human testis specific serine/threonine kinase
10/13/2005WO2005005638A3 High affinity fusion proteins (rc-scfv-fc or scfv-scfv-fc) binding cytokines, particularly il-6 & il-18
10/13/2005WO2003099779A3 Hemipteran muscarinic receptor
10/13/2005WO2003088808A3 Compositions and methods for the diagnosis and treatment of tumor
10/13/2005US20050229264 Recombinant gelatins
10/13/2005US20050229262 Peptide production
10/13/2005US20050228170 B7-like molecules and uses thereof
1 ... 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 ... 1125